Tesla halts production at Gruenheide site after power cut-February 2024-www.financetom.com

Tesla halts production at Gruenheide site after power cut

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Tesla halts production at Gruenheide site after power cut

Mar 5, 2024 1:27 AM

FRANKFURT, March 5 (Reuters) - Production at Tesla's

European gigafactory in Gruenheide near Berlin has been

halted after a fire at a nearby power pylon caused a power cut,

a spokesperson for the company said.

Previous page： Goldman to buy $1 billion of T. Rowe stock, Bloomberg News reports Next page： Alphabet's Google Reportedly Fined $425 Million for Privacy Breach in San Francisco Jury Verdict

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Goldman to buy $1 billion of T. Rowe stock, Bloomberg News reports

Sep 4, 2025

(Corrects typo in media packaging code) (Reuters) -Goldman Sachs ( GS ) will invest as much as $1 billion in T. Rowe Price Group and will partner with the asset manager to sell private market products to retail investors, Bloomberg News reported on Thursday. Goldman Sachs ( GS ) will use its balance sheet to hold equity in T. Rowe,...

Alphabet's Google Reportedly Fined $425 Million for Privacy Breach in San Francisco Jury Verdict

Sep 4, 2025

07:14 AM EDT, 09/04/2025 (MT Newswires) -- Alphabet's (GOOG, GOOGL) Google ( GOOG ) has been fined $425 million by a federal jury in San Francisco for invading users' privacy by continuing to gather data from millions of users who had turned off a tracking feature in their Google ( GOOG ) accounts, multiple media outlets reported late Wednesday. The...

Eli Lilly's Lung Cancer Drug Candidate Gets FDA Breakthrough Therapy Designation

Sep 4, 2025

07:15 AM EDT, 09/04/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Thursday its olomorasib inhibitor, in combination with Merck's ( MRK ) Keytruda, has received breakthrough therapy designation from the US Food and Drug Administration to treat certain metastatic KRAS G12C-mutant lung cancers. The designation from the FDA is based on strong results from a phase 1/2 trial...

Rithm Capital to Buy Crestline Management

Sep 4, 2025

07:14 AM EDT, 09/04/2025 (MT Newswires) -- Rithm Capital ( RITM ) said Thursday it has agreed to acquire alternative investment manager Crestline Management in a deal expected to close in Q4. With about $17 billion in assets under management, Crestline offers private credit and alternative investment strategies across direct lending, opportunistic credit, and fund liquidity solutions. ...